Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02675439
Title Safety and Efficacy of MIW815 (ADU-S100) +/- Ipilimumab in Patients With Advanced/Metastatic Solid Tumors or Lymphomas
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Aduro Biotech, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado School of Medicine Aurora Colorado 80045 United States Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21287 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Columbia University Medical Center-Herbert Irving Pavilion New York New York 10032 United States Details
University of Texas/MD Anderson Cancer Center MD Anderson PSC Houston Texas 77030-4009 United States Details
University of Utah Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field